Literature DB >> 2934083

Azathioprine suppresses the mixed lymphocyte reaction of patients with Lesch-Nyhan syndrome.

P W Szawlowski, S A Al-Safi, T Dooley, J L Maddocks.   

Abstract

The mixed lymphocyte reaction of Lesch-Nyhan patients (HGPRT deficient) was used to study the immunosuppressive effects of azathioprine and 6-mercaptopurine (6-MP). Mitogen stimulated lymphocytes of these patients are highly resistant to azathioprine and 6-MP. When both stimulator and responder lymphocytes in the MLR were HGPRT deficient, azathioprine (36 microM) was much more inhibitory than 6-MP (100 microM). Azathioprine produced inhibition of 98.2% and 78.5% compared with the values of 63.9% and 30.6% for 6-MP. The difference in inhibitory activity between azathioprine and 6-MP was reduced when normal stimulator lymphocytes were cultured with HGPRT deficient responder lymphocytes in the MLR. These results provide very strong evidence that the nucleotide metabolites of azathioprine and 6-MP are unnecessary for immunosuppression. They also suggest that azathioprine and 6-MP interfere with antigenic triggering of the MLR.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2934083      PMCID: PMC1400706          DOI: 10.1111/j.1365-2125.1985.tb05104.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Studies on the mechanism of formation of 5-mercapto-1-methyl-4-nitroimidazole, a metabolite of the immunosuppressive drug azathioprine.

Authors:  A H Chalmers
Journal:  Biochem Pharmacol       Date:  1974-07-01       Impact factor: 5.858

2.  A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine.

Authors:  D M Tidd; A R Paterson
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

3.  Sulphydryl groups on the surface of intact Ehrlich ascites tumour cells, human blood platelets and lymphocytes.

Authors:  J N Mehrishi; D R Grassetti
Journal:  Nature       Date:  1969-11-08       Impact factor: 49.962

4.  Effects of azathiprine in a disorder of uric acid metabolism and cerebral function.

Authors:  W L Nyhan; L Sweetman; D G Carpenter; C H Carter; D Hoefnagel
Journal:  J Pediatr       Date:  1968-01       Impact factor: 4.406

Review 5.  Symposium on immunosuppressive drugs. Summary and concluding remarks.

Authors:  G H Hitchings
Journal:  Fed Proc       Date:  1967 May-Jun

6.  In vitro evaluation of immunosuppressive drugs.

Authors:  J F Bach; M Dardenne; C Fournier
Journal:  Nature       Date:  1969-06-07       Impact factor: 49.962

7.  Azathioprine-induced leukopenia--clinical significance in renal transplantation.

Authors:  R Pollak; R A Nishikawa; M F Mozes; O Jonasson
Journal:  J Surg Res       Date:  1980-09       Impact factor: 2.192

8.  One-way stimulation in mixed leukocyte cultures.

Authors:  F H Bach; N K Voynow
Journal:  Science       Date:  1966-07-29       Impact factor: 47.728

9.  Frequency of leukopenia incidents following azathioprine therapy after kidney transplantation.

Authors:  H Oesterwitz; G Horpacsy; G May; M Mebel
Journal:  Eur Urol       Date:  1978       Impact factor: 20.096

10.  Azathioprine and 6-mercaptopurine (6-MP) suppress the human mixed lymphocyte reaction (MLR) by different mechanisms.

Authors:  S A Al-Safi; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

View more
  7 in total

Review 1.  The clinical pharmacology of 6-mercaptopurine.

Authors:  L Lennard
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Seeking approval: present and future therapies for pemphigus vulgaris.

Authors:  Xuming Mao; Aimee S Payne
Journal:  Curr Opin Investig Drugs       Date:  2008-05

Review 3.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

Review 4.  Comparative tolerability of treatments for inflammatory bowel disease.

Authors:  R B Stein; S B Hanauer
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

Review 5.  Maintenance of remission in Crohn's disease: current and emerging therapeutic options.

Authors:  Matthew J Brookes; Jonathon R B Green
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Metabolism of azathioprine to 6-thioguanine nucleotides in patients with pemphigus vulgaris.

Authors:  L Lennard; C I Harrington; M Wood; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

Review 7.  New immunosuppressive agents for pediatric transplantation.

Authors:  M Ferraresso; B D Kahan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.